블로그

IVIG

Cost of IVIG Treatment

Patient receiving IVIG treatment at home

Intravenous immunoglobulin (IVIG) therapy has brought about significant improvements in the lives of numerous individuals dealing with autoimmune and immunodeficiency conditions. However, this treatment can be relatively expensive. For instance, a single IVIG infusion can cost anywhere from $100 to over $350 or more per gram.

IVIG 공제금 지원 받기

IVIG 재정 지원
(877) 778-0318

On average, the reported cost for IVIG treatment in the US is approximately $9,720, and if patients undergo 4 to 5 infusions per month, then it would cost them around $41,796 per month. Even though IVIG infusions offer hope and an improved quality of life, the financial aspect can be daunting for many patients and their families. 

Therefore, if your healthcare provider prescribes IVIG therapy to you or your loved ones, it is important to be aware of the cost associated with IVIG infusion. 

In this article, we have briefly highlighted the factors contributing to IVIG infusion costs and provided some strategies that can help manage the expenses associated with IVIG infusion. 

What Makes IVIG Therapy an Expensive Treatment?

In order to create IVIG, thousands of donor plasmas must first be collected. These plasmas then go through a rigorous manufacturing and testing procedure to guarantee the product’s safety and effectiveness. This treatment is very costly due to the involved production process and strict quality control procedures. 

Besides preparation costs, several other factors also increase the cost of IVIG infusion, which include: 

  • The type of condition being treated 
  • The brand of the medication
  • Dosage requirements
  • Treatment frequency (whether it is long-term or short-term)
  • Healthcare facilities providing the service

These expenses encompass not only the medication itself but also include associated charges for medical supervision, equipment, and administration.

How Can You Reduce the Cost of  IVIG Treatment?

Although IVIG therapy can be expensive, there are several strategies that you can use to manage IVIG expenses. 

Check Insurance Coverage

Check your health insurance policy to see how much IVIG infusions are covered. Under certain medical circumstances, some insurance plans may only cover a fraction of the cost, while others may pay the full amount.

Explore Generic Alternatives

Generic equivalents are available, much like prescription medications. Consult your healthcare provider about using generic IVIG alternatives. These alternatives can significantly reduce costs while keeping the therapeutic benefits of the treatment.

Inquire About Patient Assistance Programs

Many pharmaceutical companies and nonprofit organizations offer patient assistance programs designed to lessen the financial burden of IVIG treatments. Typically, these programs extend grants, copay assistance, or alternative financial assistance options to individuals who meet the eligibility criteria.

Opt for Home Infusions

When appropriate, IVIG infusions administered at home can replace hospital or clinic treatments at a lower cost. Home infusions provide the comfort of familiar settings while significantly lowering facility expenses.

Discuss Treatment Options

Consult your healthcare provider for alternative treatment options or dosages that might be equally effective but more cost-effective.

전문가와 상담하세요

공제금 지원에 관하여
IVIG 전문가와 상담하세요

How AmeriPharma® Can Help

AmeriPharma® understands how expensive treatment can impose a financial burden on patients. That’s why our commitment lies in assisting patients on their path to improved health. Our expertise lies in facilitating connections between individuals and appropriate patient assistance programs, copay support, and various avenues aimed at alleviating the financial burdens associated with medical expenses.

Accessing Financial Support

Please 문의하기 to inquire about possible financial assistance programs. Our experienced team can guide you through the available options and help you navigate the path to affordable IVIG infusion.

결론

Overall, the cost of IVIG treatment can be quite significant, but there are methods to reduce these costs. Exploring insurance coverage, researching financial assistance programs, and working with dedicated organizations like AmeriPharma® can pave the way for affordable access to much-needed IVIG therapy. Always remember that your health and well-being come first, and there are tools available to help you throughout your healthcare journey.

참고문헌:

  1. Dangi-Garimella, S., PhD. (2022). Intravenous immunoglobulin: A quick look at treatment and insurance coverage. Patients Rising. https://www.patientsrising.org/intravenous-immunoglobulin-a-quick-look-at-treatment-and-insurance-coverage/
  2. Burt, R. K., Tappenden, P., Balabanov, R., Han, X., Quigley, K., Snowden, J. A., & Sharrack, B. (2021). The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP. Frontiers in Neurology12. https://doi.org/10.3389/fneur.2021.645263
  3. Huang F, Feuille E, Cunningham-Rundles C. (2013). Home care use of intravenous and subcutaneous immunoglobulin for primary immunodeficiency in the United States. J Clin Immunol. 33(1):49-54. doi: 10.1007/s10875-012-9776-y.
  4. Ritchie, B., Martins, K. J., Tran, D. T., Blain, H., Richer, L., & Klarenbach, S. W. (2022). Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study. Allergy, Asthma & Clinical Immunology18(1), 1-11. https://doi.org/10.1186/s13223-022-00735-6
  5. Blackhouse, G., Gaebel, K., Xie, F., Campbell, K., Assasi, N., Tarride, J. E., … & Goeree, R. (2010). Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation8(1), 1-9. https://doi.org/10.1186/1478-7547-8-14
이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 Martina Mikail 박사, PharmD

마르티나 미카일 약학박사는 이집트에서 태어나 펜실베이니아와 캘리포니아에서 자랐습니다. 2022년 5월 마셜 B. 케첨 대학교를 졸업했습니다. 미카일 박사는 USPS 리더십 어워드와 CSHP 리더십 어워드를 수상했으며, CSHP, ASHP, 그리고 APhA의 정회원으로 활동하고 있습니다. 그녀의 업무에서 가장 보람 있는 부분은 환자 교육 및 약물 상담입니다. 여가 시간에는 요리, 가족과의 시간 보내기, 그리고 독서를 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean